Amarin Corp Plc (AMRN)

[HDGabor]

I listened again: Thero said 'north of 200' (two times) - the poster 'mixed' it w Jelis subgroup

'...north of 200s, so at risk population. If one wanted to look at the results of an outcome study done with EPA, which is the active ingredient in Vascepa; (went to) [ph] look at the JELIS study in Japan which is 18,600 patients (being seen) [ph], on the left which is the overall cohort of the trial that compared to statin alone, it was a 19% reduction in cardiovascular events or relatively low risk population.

In our REDUCE-IT study where we are looking at a more at risk population, I mentioned that the mean and medium baseline triglycerides in REDUCE-IT are north of 200. The subgroup analysis for JELIS showed triglyceride levels above 150 adding a 53% reduction ...'